CapsoVision to Participate in the 38th Annual ROTH Conference
CapsoVision (NASDAQ: CV) will present at the 38th Annual ROTH Conference on Monday, March 23, 2026 in Dana Point, CA.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
CapsoVision (NASDAQ: CV) will present at the 38th Annual ROTH Conference on Monday, March 23, 2026 in Dana Point, CA. Management will host a fireside chat and hold 1x1 investor meetings at 10:30–10:55 am PT.
The fireside chat will be webcast live and archived on the company Events page for one year; investors can request one-on-one meetings via their Roth representative or Investors@CapsoVision.com.
Details
News Market Reaction – CV
On Mar 10, the first trading day after this news, CV closed 1.76% above the previous close.
Data tracked by StockTitan Argus for the Mar 10 session.
Key Figures
- Q3 2025 revenue
- $3.5 million
- Third quarter 2025 financial results
- Revenue growth
- 19%
- Q3 2025 year-over-year increase
- New accounts growth
- 31%
- Q3 2025 new accounts vs prior year
- Q3 2025 gross profit
- $1.9 million
- Third quarter 2025 results
- Q3 2025 net loss
- $7.921 million
- Quarter ended September 30, 2025 (10-Q)
- Cash and equivalents
- $17.787 million
- As of September 30, 2025 (10-Q)
- IPO net proceeds
- $23.37 million
- IPO completed July 2025 (10-Q)
- Canon agreement value
- $4.1 million
- Development agreement for CMOS sensors (10-Q)
Historical Context
-
Filed 510(k) for AI-assisted reading module for CapsoCam Plus system.
-
Announced participation in Benchmark one-on-one investor conference.
-
Higher Q3 revenue but continued losses and going-concern language disclosed.
-
Submitted FDA Breakthrough Device Designation application for pancreatic screening capsule.
-
Appointed David Garcia as Senior Vice President of Finance.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
- Company to participate in a fireside chat and 1x1 investor meetings on March 23, 2026 -
SARATOGA, Calif., March 09, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today announced that Johnny Wang, President and Chief Executive Officer, David Garcia, Senior Vice President of Finance, and Doug Atkinson, Senior Vice President of Global Sales, will participate in the 38th Annual ROTH Conference on Monday, March 23, 2026 in Dana Point, CA.
Format: Fireside Chat and 1x1 Investor Meetings
Date/Time: Monday, March 23, 2026, at 10:30–10:55 am PT
The fireside chat will be webcast live and archived on the Events page in the investor relations section of the company’s website for one year. If you are interested in arranging a one-on-one meeting with CapsoVision’s management team at the conference, please contact your Roth representative or reach out to the company directly at Investors@CapsoVision.com.
About CapsoVision
CapsoVision is a commercial-stage medical technology company focused on developing advanced imaging and AI-enabled solutions to transform the detection and diagnosis of gastrointestinal diseases. Its flagship product, CapsoCam Plus®, is a wire-free, panoramic capsule endoscope that enables high-resolution visualization of the small bowel and supports cloud-based or direct capsule video retrieval. The Company’s next pipeline product, CapsoCam Colon™ with enhanced AI, is designed to enable non-invasive colon imaging and polyp detection. With a proprietary platform targeted to expand across multiple GI indications, including esophageal and pancreatic disorders, CapsoVision is advancing a new era in capsule-based diagnostics. For more information on CapsoVision, please visit www.capsovision.com.
Investor Relations Contact
Leigh Salvo
New Street Investor Relations
Investors@CapsoVision.com
Media Contact
Leslie Strickler and Paul Spicer
Être Communications
leslies@etrecommunications.com | (804) 240-0807
pauls@etrecommunications.com | (804) 503-9231
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.